Trial Profile
Clarify of Predictive Risk Factors of Chemotherapy-induced Liver Injury After Therapy With Docetaxel and Cisplatin for Nasopharyngeal Carcinoma
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 11 Feb 2019
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Docetaxel (Primary)
- Indications Liver injury; Nasopharyngeal cancer
- Focus Pharmacodynamics
- 07 Mar 2017 New trial record